[go: up one dir, main page]

NO20075090L - Fremgangsmate for administrering av ixabepilone - Google Patents

Fremgangsmate for administrering av ixabepilone

Info

Publication number
NO20075090L
NO20075090L NO20075090A NO20075090A NO20075090L NO 20075090 L NO20075090 L NO 20075090L NO 20075090 A NO20075090 A NO 20075090A NO 20075090 A NO20075090 A NO 20075090A NO 20075090 L NO20075090 L NO 20075090L
Authority
NO
Norway
Prior art keywords
ixabepilone
administration
patients
dual
stability
Prior art date
Application number
NO20075090A
Other languages
English (en)
Inventor
Ismat Ullah
Vijay H Naringrekar
Thomas A Haby
Fahri T Comezoglu
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO20075090L publication Critical patent/NO20075090L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det er gitt metoder for administrering av ixabepilone til pasienter, hvor ixabepilone har formelen . Ett aspekt ved oppfinnelsen omfatter anvendelse av en Y-kobling eller dualkilde administreringsteknikk som gir forbedret ixabepilone-stabilitet og tillater større fleksibilitet i infusjonstid og/eller produktfremstilling.
NO20075090A 2005-03-31 2007-10-09 Fremgangsmate for administrering av ixabepilone NO20075090L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66690705P 2005-03-31 2005-03-31
PCT/US2006/011920 WO2006105399A1 (en) 2005-03-31 2006-03-30 Methods for administering ixabepilone

Publications (1)

Publication Number Publication Date
NO20075090L true NO20075090L (no) 2007-12-04

Family

ID=36763031

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20075090A NO20075090L (no) 2005-03-31 2007-10-09 Fremgangsmate for administrering av ixabepilone

Country Status (5)

Country Link
EP (1) EP1863481A1 (no)
JP (1) JP2008534610A (no)
CN (1) CN101155584A (no)
NO (1) NO20075090L (no)
WO (1) WO2006105399A1 (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009089138A1 (en) * 2008-01-04 2009-07-16 Bristol-Myers Squibb Company Oral administration of ixabepilone
EP2227296B1 (en) 2008-01-08 2015-11-25 Bristol-Myers Squibb Company Combination of anti-ctla4 antibody with tubulin modulating agents for the treatment of proliferative diseases
NZ613167A (en) 2010-12-16 2015-09-25 Univ Texas Azole pharmaceutical formulations for parenteral administration and methods for preparing and using the same as treatment of diseases sensitive to azole compounds
ES2822350T3 (es) 2011-04-28 2021-04-30 Platform Brightworks Two Ltd Formulaciones parenterales mejoradas de agentes farmacéuticos lipófilos y procedimientos de preparación y uso de las mismas
CN103908432B (zh) * 2013-01-02 2018-09-21 博瑞生物医药（苏州）股份有限公司 一种伊沙匹隆白蛋白的冻干组合物及其制备方法
US9320730B2 (en) * 2014-03-13 2016-04-26 Vasilios Voudouris Bendamustine solid dispersions and continuous infusion

Also Published As

Publication number Publication date
CN101155584A (zh) 2008-04-02
EP1863481A1 (en) 2007-12-12
WO2006105399A1 (en) 2006-10-05
JP2008534610A (ja) 2008-08-28

Similar Documents

Publication Publication Date Title
ECSP067054A (es) Nuevos derivados fluoroglicosídicos de pirazoles, medicamentos que contienen estos compuestos, y el empleo de los mismos
PH12019500599A1 (en) Sweet flavor modifier
NZ753358A (en) Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
MY179876A (en) Sweet flavor modifier
SG178952A1 (en) Chemical compounds
NO20065946L (no) DPP-IV-inhibitorer
NO20075090L (no) Fremgangsmate for administrering av ixabepilone
TW200716646A (en) (S)-N-methylnaltrexone
NO20075669L (no) Middel for a behandle ufrivillig bevegelse
MX2007007845A (es) Sulfonilpirrolidinas, metodo para producir las mismas y su uso como medicamento.
BR112014033104A2 (pt) composições pesticidas e processos relacionados a estas
WO2009111653A3 (en) Antiviral therapeutic agents
NO20083026L (no) Terapeutisk middel for diabetes
MX2011011776A (es) Nuevos profarmacos de triptolite.
WO2007076085A3 (en) Fused pyrimidones and thiopyrimidones, and uses thereof
UA112556C2 (uk) Інсектицидні похідні 2-метоксибензамідів
CY1117397T1 (el) Παραγωγα 3-ετεροαρουλαμινο-προπιονικου οξεος και χρηση τους ως φαρμακευτικα
CY1118844T1 (el) Υποκατεστημενα παραγωγα 3-ετεροαροϋλαμινο-προπιονικου οξεος και χρηση τους ως φαρμακευτικα
MX2009000768A (es) Lactamas macrociclicas.
DK2471781T3 (da) Benzylaralkylether-forbindelser, fremgangsmåde til fremstilling af samme, mel-lemproduktforbindelser, anvendelse af disse forbindelser, fremgangsmåde til behandling og/eller forebyggelse, farmaceutisk sammensætning og medikament, som indeholder samme.
UA100862C2 (ru) Шестичленные ароматические соединения, их получение и применение (варианты)
NO20063611L (no) Fremgangsmater for fremstilling av aryl- og heteroarylsulfonylhalider
ATE556062T1 (de) 3,4-dihydrochinazolinderivate
NO20091386L (no) Fenyloksyanilinderivater
DK1615656T3 (da) Immunmodulerende produkt opnået ud fra en Bifidobacterium-kultur og præparater indeholdende samme

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application